MATARESE, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 4.285
EU - Europa 1.107
AS - Asia 677
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 4
AF - Africa 1
SA - Sud America 1
Totale 6.085
Nazione #
US - Stati Uniti d'America 4.159
UA - Ucraina 531
CN - Cina 481
IE - Irlanda 134
IT - Italia 131
DE - Germania 128
CA - Canada 125
VN - Vietnam 119
FI - Finlandia 111
TR - Turchia 58
SE - Svezia 40
EU - Europa 10
IN - India 10
GB - Regno Unito 8
FR - Francia 7
RU - Federazione Russa 6
NZ - Nuova Zelanda 3
BE - Belgio 2
HK - Hong Kong 2
KR - Corea 2
LU - Lussemburgo 2
SG - Singapore 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
BS - Bahamas 1
CH - Svizzera 1
ES - Italia 1
HR - Croazia 1
IL - Israele 1
MA - Marocco 1
NL - Olanda 1
TW - Taiwan 1
Totale 6.085
Città #
Ann Arbor 1.158
Jacksonville 624
Chandler 502
Princeton 416
Wilmington 275
Woodbridge 177
Nanjing 149
Dublin 133
Dong Ket 119
Andover 113
Ottawa 113
Houston 103
Boardman 79
Pellezzano 74
Ashburn 73
Izmir 57
Shenyang 49
Changsha 43
Fairfield 40
Nanchang 38
Beijing 35
Hebei 33
Jinan 30
Jiaxing 29
Norwalk 29
Tianjin 28
Mestre 16
Düsseldorf 11
Cambridge 9
Hangzhou 9
Pune 8
San Diego 8
Ningbo 7
Seattle 6
Falls Church 5
Guangzhou 5
Salerno 5
Lanzhou 4
Los Angeles 4
Oshawa 4
Taiyuan 4
Tappahannock 4
Dearborn 3
Irkutsk 3
Moscow 3
Mountain View 3
New York 3
Redwood City 3
Auckland 2
Brussels 2
Dormagen 2
Edinburgh 2
Fuzhou 2
Genova 2
Haikou 2
Indiana 2
London 2
Montreal 2
Paris 2
Rome 2
Venezia 2
Zelarino 2
Zhengzhou 2
Acton 1
Andorra la Vella 1
Angier 1
Atlanta 1
Avella 1
Boston 1
Calgary 1
Clearwater 1
Cormeilles-en-Parisis 1
Delhi 1
Falkenstein 1
Fisciano 1
Gorey 1
Groningen 1
Hanover 1
Huntsville 1
Islington 1
Istanbul 1
Kabul 1
Lansing 1
Legnago 1
Lioni 1
Luxembourg 1
Madrid 1
Melbourne 1
Montréal 1
Munich 1
Naples 1
Nassau 1
New Albany 1
New Delhi 1
Ohsweken 1
Palmerston North 1
Pisogne 1
Rabat 1
Redmond 1
Regina 1
Totale 4.713
Nome #
Leptin in autoimmune diseases 106
Regulatory T cells, leptin and angiogenesis 99
Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis 95
Metabolic fuelling of proper T cell functions 95
Animal models of Multiple Sclerosis 92
Regulatory T cells, inflammation, and endoplasmic reticulum stress in women with defective endometrial receptivity 90
Leptin promotes lupus T-cell autoimmunity 87
The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus 87
Resveratrol Couples Apoptosis with Autophagy in UVB-Irradiated HaCaT Cells 86
Regulatory T cell proliferative potential is impaired in human autoimmune disease 82
Leptin enhances availability of apoptotic cell-derived self-antigen in systemic lupus erythematosus 77
The Cellular and Molecular Basis of Translational Immunometabolism 75
Neuro-endocrine networks controlling immune system in health and disease 72
Immune-metabolic profiling of anorexic patients reveals an anti-oxidant and anti-inflammatory phenotype 72
An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. 71
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate 71
Obesity and susceptibility to autoimmune diseases. 70
Aspirin reduces the outcome of anticancer therapy in Meth A-bearing mice through activation of AKT-glycogen synthase kinase signaling. 67
At the crossroad of T cells, adipose tissue, and diabetes. 67
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants 65
A key role of leptin in the control of regulatory T cell proliferation. 64
Meta-immunological profiling of children with type 1 diabetes identifies new biomarkers to monitor disease progression. 64
Biochemical, pathological, and skeletal improvement of mucopolysaccharidosis VI after gene transfer to liver but not to muscle. 63
A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice. 63
Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses. 63
Allelic distribution of human leucocyte antigen in historical and recently diagnosed tuberculosis patients in Southern Italy. 62
Polychlorinated Biphenyls Induce Mitochondrial Dysfunction in SH-SY5Y Neuroblastoma Cells 62
Association of pelvic endometriosis with alopecia universalis, autoimmune thyroiditis and multiple sclerosis. 61
Oscillatory mTOR inhibition and Treg increase in kidney transplantation 61
Balancing susceptibility to infection and autoimmunity: a role for leptin? 60
Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. 60
Editorial: acute inflammation in obesity: IL-17A in the middle of the battle. 60
In vivo veritas, in vitro artificia 60
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis 60
Hunger-promoting hypothalamic neurons modulate effector and regulatory T-cell responses. 58
Leptin signaling: A key pathway in immune responses. 57
Cutting edge: Leptin-induced ROR?t expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus. 57
T cell metabolism and susceptibility to autoimmune diseases 57
Leptin modulates autophagy in human CD4+CD25- conventional T cells 57
HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway. 56
Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans. 55
The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice. 55
Ob-stopping obesity, metabolic and immune-mediated disorders. 55
Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia. 55
Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. 54
The role of CD4-Lck in T-cell receptor antagonism: evidence for negative signaling. 54
T cell activation deficiency associated with an aberrant pattern of protein tyrosine phosphorylation after CD3 perturbation in Down's syndrome. 54
Histamine regulates autoreactive T cell activation and adhesiveness in inflamed brain microcirculation. 54
Regulatory T cells, mTOR kinase, and metabolic activity. 54
Role of Adipokines Signaling in the Modulation of T Cells Function 54
Unraveling the multiple roles of leptin in inflammation and autoimmunity. 53
"Eczemas" and leptin. 53
Immunological functions of leptin and adiponectin 53
Imbalance of circulating dendritic cell subsets in chronic obstructive pulmonary disease 53
Modulation of CD45 tyrosine phosphatase activity by antigen. 52
The Yin and Yang of CD4(+) regulatory T cells in autoimmunity and cancer. 52
Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting. 52
Defective dendritic cell maturation in a child with nucleotide excision repair deficiency and CD4 lymphopenia. 52
Serum concentrations of soluble human leukocyte class I antigens and of the soluble intercellular adhesion molecule-1 in endometriosis: relationship with stage and non-pigmented peritoneal lesions. 52
Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients 52
Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet. 51
Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. 50
Leptin as a novel therapeutic target for immune intervention. 50
Regulatory CD4 T cells: sensing the environment. 50
Leptin in intestinal inflammation: good and bad gut feelings. 50
Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance. 50
Leptin and Inflammation. 50
Leptin: the prototypic adipocytokine and its role in NAFLD. 49
Leptin concentrations in the peritoneal fluid of women with ovarian endometriosis are different according to the presence of a 'deep' or 'superficial' ovarian disease. 49
Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. 49
High serum leptin in patients with chronic graft-versus-host disease after hematopoietic stem cell transplantation. 49
The fine specificity of human T cell lines towards myelin basic protein peptides in southern Italian multiple sclerosis patients. 48
Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis. 48
Leptin in non-autoimmune inflammation. 47
Leptin accelerates autoimmune diabetes in female NOD mice. 47
Immune phenotype and serum leptin in children with obesity-related liver disease. 47
The bioenergetics of the immune system. 47
Leptin as an immunomodulator. 46
Leptin as clinical target. 46
Serum leptin and CD4+ T lymphocytes in HIV+ children during highly active antiretroviral therapy. 45
Cutting edge: fasting-induced hypoleptinemia expands functional regulatory T cells in systemic lupus erythematosus. 45
Leptin is an effective treatment for hypothalamic amenorrhea. 45
The weight of leptin in immunity. 44
Intracellular metabolic pathways control immune tolerance. 44
Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis. 44
Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? 44
Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. 44
Leptin in immunology. 43
Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome. 43
The peritoneal fluid concentration of leptin is increased in women with peritoneal but not ovarian endometriosis. 43
Effects of human immunodeficiency virus type 1 on CD4 lymphocyte subset activation. 43
Leptin as a metabolic link to multiple sclerosis. 43
The intricate interface between immune system and metabolism. 42
Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. 42
Leptin and the immune system: how nutritional status influences the immune response. 42
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 42
Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. 40
Leptin modulates the survival of autoreactive CD4+ T cells through the nutrient/energy-sensing mammalian target of rapamycin signaling pathway. 40
Leptin in autoimmunity: many questions, some answers. 40
Regulatory T cells in obesity: the leptin connection. 40
Totale 5.720
Categoria #
all - tutte 17.345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.345


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019165 0 0 0 0 0 0 0 0 0 64 97 4
2019/20201.081 320 7 114 0 90 2 111 2 110 142 141 42
2020/2021877 76 99 114 2 110 16 112 1 115 0 101 131
2021/2022702 0 0 0 10 3 6 13 35 120 105 78 332
2022/20231.144 127 68 14 120 185 264 0 110 175 4 58 19
2023/2024262 59 76 14 18 17 21 35 17 0 5 0 0
Totale 6.203